Monopar Therapeutics (MNPR) R&D In Process (2017)
Historic R&D In Process for Monopar Therapeutics (MNPR) over the last 1 years, with Q3 2017 value amounting to $14.5 million.
- Monopar Therapeutics' R&D In Process changed N/A to $14.5 million in Q3 2017 from the same period last year, while for Dec 2018 it was $14.5 million, marking a year-over-year change of. This contributed to the annual value of $14.5 million for FY2017, which is N/A changed from last year.
- As of Q3 2017, Monopar Therapeutics' R&D In Process stood at $14.5 million.
- Monopar Therapeutics' R&D In Process' 5-year high stood at $14.5 million during Q3 2017, with a 5-year trough of $14.5 million in Q3 2017.